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Background: Addiction treatment faces high pretreatment and treatment dropout rates, especially among
Aboriginals. In this study we examined characteristic differences between Aboriginal and non-Aboriginal clients
accessing an inpatient medical withdrawal management program, and identified risk factors associated with the
probabilities of pretreatment and treatment dropouts, respectively.
Methods: 2231 unique clients (Aboriginal = 451; 20%) referred to Vancouver Detox over a two-year period were
assessed. For both Aboriginal and non-Aboriginal groups, multivariate logistic regression analyses were conducted
with pretreatment dropout and treatment dropout as dependent variables, respectively.
Results: Aboriginal clients had higher pretreatment and treatment dropout rates compared to non-Aboriginal clients
(41.0% vs. 32.7% and 25.9% vs. 20.0%, respectively). For Aboriginal people, no fixed address (NFA) was the only predictor
of pretreatment dropout. For treatment dropout, significant predictors were: being female, having HCV infection, and
being discharged on welfare check issue days or weekends. For non-Aboriginal clients, being male, NFA, alcohol
as a preferred substance, and being on methadone maintenance treatment (MMT) at referral were associated with
pretreatment dropout. Significant risk factors for treatment dropout were: being younger, having a preferred substance
other than alcohol, having opiates as a preferred substance, and being discharged on weekends.
Conclusions: Our results highlight the importance of social factors for the Aboriginal population compared to
substance-specific factors for the non-Aboriginal population. These findings should help clinicians and decision-makers
to recognize the importance of social supports especially housing and initiate appropriate services to improve treatment
intake and subsequent retention, physical and mental health outcomes and the cost-effectiveness of treatment.
Keywords: Aboriginal, Housing, Pretreatment dropout rate, Treatment dropout rate, Withdrawal management,
Substance use disorders, DetoxificationBackground
Substance use disorders (SUD) are a common problem
and a major issue of concern for Canada’s Aboriginal
population [1]. Aboriginal people are also overrepre-
sented among HIV and AIDS cases in Canada. They rep-
resented 3.8% of the Canadian population [2], and yet* Correspondence: aslam.anis@ubc.ca
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reproduction in any medium, provided the oraccounted for 8.0% of all prevalent HIV infections and
12.5% of new infections in 2008. The estimated new
infection rate among Aboriginal people was about 3.6
times higher than that among non- Aboriginal people.
In addition, the proportion of estimated new HIV infec-
tions in 2008 among Aboriginal people who inject drugs
(66%) was also much higher than that among all Canadians
(17%) [3].
British Columbia (BC) had the second largest Aboriginal
population among all Canadian provinces, representing 5%
of the provincial population, and the census metropolitanhis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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any city in BC [2]. Vancouver’s Downtown Eastside (DTES)
is the most impoverished urban neighborhood in Canada
and is the centre of the injection drug epidemic in Vancou-
ver; 4,700 injection drug users (IDUs) were estimated to
live in DTES in 2000 [4]. Previous studies on Vancouver
have shown that Aboriginal people are overrepresented
among injection drug users (IDUs) in DTES, are becoming
HIV positive at twice the rate of non-Aboriginal IDUs,
have a six-fold higher incidence of acute hepatitis C infec-
tion (HCV) and are more likely to be co-infected with HIV
and HCV compared to the non-Aboriginal population.
In addition, they also have higher rates of drug-induced
deaths [5].
Although previous studies have shown that addiction
treatment programs are effective in reducing substance
use, in improving clients’ health and social function and
in reducing public health and safety risks [6-8], they face
high pretreatment and treatment dropout rates, ranging
from 28% to 50% [9-11] and 20% to 46% [12-14], re-
spectively. Several studies have examined correlates of
treatment dropout rates from drug and alcohol detoxifica-
tion programs [15-22]. Although there was no consensus
on whether or not specific features of a detoxification pro-
gram significantly improve client retention, these studies
did identify several client-related factors that were related
to the treatment dropout rate, such as age [15,16,21], edu-
cation [16,18], living condition [18], presence of legal
problems [16,17], substance use pattern [15,17,19,21], and
timing of welfare payments [21]. However, little research
has been carried out to provide clinically relevant research
on appropriate treatment for Aboriginal populations. The
only study, which examined risk factors associated with
dropout among Aboriginal people, found that a preferred
drug other than alcohol and self-referral were two signi-
ficant predictors of treatment dropout for this group of
people [20].
Vancouver has a wide range of addiction services in-
cluding a multilevel withdrawal management continuum
[23]. The aim of this study was to examine characteristic
differences between Aboriginal and non-Aboriginal cli-
ents accessing an inpatient medical withdrawal manage-
ment program in Vancouver. In addition, we identified
risk factors associated with pretreatment and treat-
ment dropout rates for the two populations. Specific-
ally, based on previous literature, the present study
hypothesized that in addition to the factors such as socio-
demographics, current substance use, and IDU-related
diagnoses, day of discharge in relation to treatment drop-
out might also affect treatment dropout as it is possible
that different staffing on weekdays versus weekends
or some special events, such as once-a-month welfare
check issuance (welfare Wednesday), might contribute to
client dropout.Methods
Study sample
The sample consisted of 2231 individuals who called
ACCESS 1 requesting service at Vancouver Detox (VD)
between July 1, 2003 and June 30, 2005. For those clients
who called multiple times, only the first referral during
the study period was included. Despite the multicul-
tural nature of Vancouver, no ethnic group other than
European/White and Aboriginal represented 5% or more
of the total in our sample, therefore, the present study fo-
cused on the Aboriginal versus non-Aboriginal groups.
Ethical Approval was obtained from the Behavioural Re-
search Ethics Board at the University of British Columbia.
Treatment setting
VD offers a medically managed 24-bed mixed-gender in-
patient withdrawal management treatment in Vancouver,
British Columbia. It is staffed by a multidisciplinary
team, consisting of addiction medicine physicians, nurses,
health care workers, intake workers, and alcohol and drug
(A&D) counselors. It provides 24-hour nursing staff, onsite
medical assessment and treatment, and medical manage-
ment of withdrawal symptoms and other identified health
concerns. Vancouver Detox can be accessed free of charge
by anyone registered with a provincial medical services
plan and living in the Vancouver Coastal Health catchment
area. Thus, there are no financial barriers to treatment.
The entry point to VD is by ACCESS 1, a central tele-
phone intake service. After an initial telephone screen-
ing, ACCESS 1 determines whether the client is eligible
for the service. The main eligibility criteria for VD are:
1) above the age of fifteen, 2) having unstable medical or
psychiatric conditions, and/or 3) having a history pre-
dictive of severe withdrawal, and 4) not pregnant at the
time of call. If the client meets the criteria for VD, he/she
is either admitted to VD immediately or placed on a wait-
list for a bed to become available. Once admitted, the clin-
ical staff complete a comprehensive assessment and
develop an individualized treatment plan. During the ad-
mission, the client participates in various rehabilitative pro-
grams, including such activities as: individual counseling,
educational groups, 12-step programs, acupuncture and
other alternate therapies. Clients admitted on methadone
maintenance are maintained on this medication through-
out the admission. Clients are either discharged by success-
fully completing the program or voluntarily dropping out
by terminating against medical advice (AMA). Upon dis-
charge clients are referred to other services as required.
Data
During the initial phone interview, ACCESS1 staff
collect some basic information such as age, gender, ad-
dress, and conduct a brief addiction assessment using a
Vancouver Coastal Health Authority on-line, real-time
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(PARIS) database. Once a client is admitted to the VD,
an intake worker verifies the information inputted by
ACCESS1 and completes a more comprehensive assess-
ment which is entered into the database. During the ad-
mission, the VD staff update the clinical information in
PARIS until the client is discharged.
The PARIS database is comprehensive and includes
many variables. For the purpose of this study the follow-
ing variables were extracted: clients’ unique identification
(PARIS number), demographic information (age, gender,
ethnicity, parenting status), housing information (no fixed
address (NFA) vs. others), system characteristics (referral,
admission, and discharge dates), substance use disorder-
related information (substances recently used, primary
preferred substance(s), discharge reason, if on existing
methadone maintenance, and pre-existing IDU-related
diagnoses such as hepatitis C (HCV) or HIV infection).
Statistical analyses
Contingency table analysis (the Chi-square test) and the
Wilcoxon rank-sum test were used for bivariate compar-
isons of categorical and continuous variables, respect-
ively. For both Aboriginal and non-Aboriginal groups,
logistic regression analyses were performed separately
with pretreatment dropout and treatment dropout as the
dependent variables. For comparison purpose, variables
that were significant at p < 0.25 in either bivariate analysis
were subsequently entered into the multivariate logistic
regression models for both Aboriginal and non-Aboriginal
groups. Odds ratios (ORs) and 95% confidence intervals
(CIs) were computed. All statistical analyses were per-
formed using SAS 8.2 software program [24].
Results
Among 2231 unique clients who were referred by
ACCESS1 to VD during the study period, 451 (20%)
clients self identified as Aboriginal. Compared with
the non-Aboriginal group at referral, the Aboriginal
group was younger, more likely to be female and NFA,
and had higher rates of HIV and HCV. In addition, the
Aboriginal group had proportionately more poly-drug
users (Table 1).
Among the referred clients, 767 (34%) dropped out
without engaging in treatment. Among these, 185 clients
were Aboriginal. The pretreatment dropout rate for
Aboriginals was therefore 41%, whereas the rate was
32.7% for the non-Aboriginal group. For 1464 clients
who initiated treatment, 309 (21.1%) left the service
AMA. Among these, 69 were Aboriginal. As a result, the
treatment dropout rates for the Aboriginal and non-
Aboriginal groups were 25.9% and 20.0%, respectively. In
addition, our data indicated that the pretreatment dropouts
accounted for the major proportion of total dropouts forboth groups, representing 72.8% for the Aboriginal group
and 70.8% for the non-Aboriginal group.
Results of the bivariate and multivariate analyses
on pretreatment dropout for both the Aboriginal and
non-Aboriginal groups are presented in Table 2. For the
Aboriginal group, without fixed address (OR = 1.75, 95%
CI 1.10 – 2.79) was the only significant predictor of pre-
treatment dropout. For the non-Aboriginal group, our
results showed that females (OR = 0.72, 95% CI 0.57 –
0.91) were less likely to be pretreatment dropouts than
their counterparts. On the other hand, the probability of
pretreatment dropout was higher for people without
fixed address (OR 1.87, 95% CI 1.40 – 2.48). Clients whose
primary preferred substance was alcohol were more likely
to be pretreatment dropouts than clients whose pre-
ferred substance was other than alcohol (OR = 1.77,
95% CI 1.36 – 2.30). In addition, clients on methadone
maintenance treatment (MMT) at referral had higher
probability of pretreatment dropout (OR = 2.30, 95% CI
1.40 – 3.79).
Table 3 presents the bivariate and multivariate analyses
on treatment dropout for both the Aboriginal and non-
Aboriginal groups. Our final multivariate logistic analysis
showed that for the Aboriginal group, females (OR = 2.07,
95% CI 1.03 – 4.15) and clients who reported to have HCV
(OR = 4.91, 95% CI 2.43 – 9.94) were more likely to drop
out of treatment. In addition, compared to clients who dis-
charged in other days, clients who discharged during the
weekend (OR = 2.28, 95% CI 1.04 – 5.01) or during 3-day
welfare check issue periods (OR = 2.84, 95% CI 1.06 –
7.59) were more likely to be treatment dropouts. In
the non-Aboriginal group, older clients (annual change
OR = 0.97, 95% CI 0.96 – 0.99) and clients whose primary
preferred substance was alcohol (OR 0.72, 95% CI 0.53 –
0.99) were less likely to drop out of treatment. On the
other hand, clients who used opiates as primary preferred
substance (OR = 1.63, 95% CI 1.08 – 2.46), and clients who
discharged during weekend (OR = 2.44, 95% CI 1.71 –
3.46) were more likely to be treatment dropouts. There
was no significant impact of welfare issuance on non-
Aboriginals.
Discussion
Aboriginal people in Canada are facing a lot of social
challenges. Historical policies that legalized racial iden-
tities and systemic inequity, and cast Aboriginal people
to the margins of Canadian societies still extract consid-
erable influence on the social, cultural, political and spir-
itual inequities that Aboriginal people endure [25].
Specifically, Aboriginal adults are more likely to experi-
ence social exclusion, less likely to access economic re-
sources and opportunities such as participation in paid
work and therefore more likely to have low income and
be homeless [25] and are overrepresented in custody
Table 1 Comparisons between aboriginal and non-aboriginal clients who were referred to Vancouver Detox (N = 2231)
Variable N Aboriginal N (%) Non-aboriginal N (%) P value
2231 451 1780 .
Age (years (SD)) 37.8 (9.1) 41.2 (11.4) <0.0001
Female 788 207 (46.0) 581 (32.8) <0.0001
Dependent children 184 40 (8.9) 144 (8.1) 0.5910
Self-referrals 2126 434 (96.2) 1692 (95.1) 0.2928
No fixed address (NFA) 362 105 (23.3) 257 (14.4) <0.0001
HIV positive 153 71 (15.7) 82 (4.6) <0.0001
Hepatitis C 671 207 (45.9) 464 (26.1) <0.0001
Alcohol as primary substance of choice 1321 286 (64.6) 1035 (59.1) 0.0363
Cocaine as primary substance of choice* 759 200 (45.1) 559 (31.9) <0.0001
Opiates as primary substance of choice** 381 72 (16.3) 309 (17.7) 0.4889
Poly-drug use 661 160 (36.2) 501 (28.6) 0.0019
Methadone prescribed 92 20 (4.4) 72 (4.0) 0.7101
*Cocaine group includes cocaine, crack cocaine.
**opiates group includes heroin, methadone, oxycodone, other opiates.
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Aboriginal children are overrepresented in the Canada
child welfare system [27]. Moreover, they have been shown
to bear a disproportionate burden of illness, substance use
disorders, and disease in Canadian society [1]. In our sam-
ple, Aboriginal individuals, who accounted for approxi-
mately 5% of the BC provincial population, comprised 20%
of clients in the VD. In addition, our findings showed that
Aboriginal clients appeared to be different from their non-
Aboriginal counterparts in terms of age, gender, housing
status, substance use pattern and pre-existing IDU-related
diagnoses. The multivariate logistic analyses also revealed
different risk factors of pretreatment and treatment drop-
out rates for the two groups. These findings reinforce the
need for culturally appropriate services for AboriginalsTable 2 Bivariate and multivariate logistic regression of pretre
Aboriginal (N = 4
Bivariate analysis Multiv
Variables P value OR
Age 0.48 0.99
Female 0.24 0.97
Dependent children (Yes) 0.14 0.56
No fixed address (NFA) 0.01 1.75†
Alcohol as primary substance of choice 0.01 1.40
Cocaine as primary substance of choice 0.02 0.77
Opiates as primary substance of choice 0.23 0.93
Poly-drug use (Yes) 0.03 0.71
Methadone prescribed (Yes) 0.58 1.04
*P-value for Hosmer and Lemeshow goodness of fit test was 0.63.
**P-value for Hosmer and Lemeshow goodness of fit test was 0.53.
†Statistically significant at p < 0.05.who are at a greater risk for negative outcomes within the
current addiction treatment system.
It was interesting to show that rather than demo-
graphic or substance use-related information, lack of a
fixed address was the only factor that was significantly
associated with pretreatment dropout for Aboriginal cli-
ents. To prevent attrition early in the treatment phase for
this group of clients, our findings suggest that interven-
tions such as providing these homeless clients with tem-
porary accommodations will allow treatment staff to more
easily reach them once beds are available and to cater to
their immediate health needs. This could also then im-
prove treatment initiation significantly. Our findings are
consistent with the findings found by “At Home” study. In
2008, the Government of Canada allocated $110 million toatment dropout for aboriginal and non-aboriginal clients
51) Non-aboriginal (N = 1780)
ariate analysis* Bivariate analysis Multivariate analysis**
95% CI P value OR 95% CI
(0.96, 1.01) 0.16 0.99 (0.98, 1.00)
(0.64, 1.48) 0.00 0.72† (0.57, 0.91)
(0.27, 1.19) 0.04 0.73 (0.49, 1.09)
(1.10, 2.79) 0.00 1.87† (1.40, 2.48)
(0.86, 2.25) 0.00 1.77† (1.36, 2.30)
(0.49, 1.19) 0.23 1.25 (0.97, 1.61)
(0.49, 1.77) 0.38 0.99 (0.72, 1.37)
(0.43, 1.17) 0.73 0.99 (0.74, 1.32)
(0.38, 2.83) 0.01 2.30† (1.40, 3.79)
Table 3 Bivariate and multivariate logistic regression of treatment dropout for aboriginal and non-aboriginal clients
Aboriginal (N = 266) Non-aboriginal (N = 1198)
Bivariate analysis Multivariate analysis* Bivariate analysis Multivariate analysis**
Variables P value OR 95% CI P value OR 95% CI
Age 0.22 1.00 (0.96, 1.04) 0.00 0.97† (0.96, 0.99)
Female 0.02 2.07† (1.03, 4.15) 0.18 1.00 (0.72, 1.37)
Dependent children (Yes) 0.09 2.15 (0.83, 5.59) 0.93 1.07 (0.64, 1.80)
No fixed address (NFA) 0.32 1.53 (0.71, 3.31) 0.11 1.09 (0.70, 1.70)
Hepatitis C (Yes) 0.00 4.91† (2.43, 9.94) 0.02 1.41 (0.98, 2.02)
HIV positive (Yes) 0.48 0.49 (0.20, 1.17) 0.22 0.47 (0.21, 1.07)
Alcohol as primary substance of choice 0.04 1.21 (0.59, 2.48) 0.00 0.59† (0.40, 0.85)
Cocaine as primary substance of choice 0.02 1.62 (0.77, 3.40) 0.81 0.73 (0.51, 1.05)
Opiates as primary substance of choice 0.00 2.09 (0.89, 5.05) 0.00 1.63† (1.08, 2.46)
Poly-drug use (Yes) 0.01 1.28 (0.59, 2.78) 0.01 0.93 (0.63, 1.39)
Days of discharge‡ 0.22 0.00
Weekend 2.28† (1.04, 5.01) 2.44† (1.71, 3.46)
Welfare check issue period 2.84† (1.06, 7.59) 1.51 (0.96, 2.38)
*P-value for Hosmer and Lemeshow goodness of fit test was 0.60. **P-value for Hosmer and Lemeshow goodness of fit test was 0.84.
†Statistically significant at p < 0.05.
‡The reference category was being discharged on other weekdays. Welfare check issue periods were defined as welfare Wednesday, one day before (Tuesday)
and one day after (Thursday).
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undertake the “At Home” study, a four-year project in
five cities that aimed to provide practical, meaningful
support to Canadians experiencing homelessness and
mental health problems. The preliminary result of the
study has shown that implementing a Housing First strat-
egy can significantly improve homeless clients with mental
illness and/or SUD to access the type of care that is vital
for recovery [28].
For the non-Aboriginal group, in addition to NFA, we
found that several other factors such as being male, alco-
hol as a preferred substance, and being on MMT at refer-
ral were also associated with dropout before treatment.
Previous studies have shown that longer delay between
the initial phone contact and the scheduled appointment
is negatively associated with treatment initiation [29,30].
However, the tolerance for delay and reasons for delay
might vary for different clients. Specifically, those with al-
cohol alone, as the problem substance, may be receiving
treatment services from a primary care physician or emer-
gency room and be prescribed benzodiazepines for out-
patient management of withdrawal and thus preventing
the need for admission. On the other hand, clients en-
rolled in MMT at referral might have a longer wait time
than other clients because of the need to coordinate the
date and time of last dose taken in the community and to
maintain continuity of MMT.
With regards to treatment dropout, our results also
showed completely different sets of factors that were as-
sociated with treatment dropout AMA for the Aboriginaland non-Aboriginal groups. Specifically, Aboriginal but
not other clients being HCV positive was associated with
increased risk of leaving AMA compared to those who
did not have this disease. HCV + status may be a marker
for more severe dependence and injection drug use [31]
as well as increased social marginalization [32,33]. In
addition, previous literature has shown that there are sig-
nificant increases in hospital admission, emergency de-
partment admission, emergency calls and deaths shortly
after the distribution of monthly welfare cheques [34,35].
Our data showed that this was also a factor for Aboriginal
clients at VD.
In contrast to our findings, Callaghan’s study found
that a preferred drug other than alcohol and self-referral
were significantly associated with treatment dropout for
Aboriginals [20]. Callaghan’s sample contained a large
proportion of Aboriginal clients who were referred to
the service by other sources such as from physicians or
social service or mental health care providers. However, in
the present study, the majority of the Aboriginal people
(96%; data not shown) were self-referred. In addition, our
study focused exclusively on urban Aboriginals, whereas
Callaghan’s data was from a rural setting and included
30% who reported their primary residence as “on-reserve”.
Further study is warranted to clarify the different treat-
ment needs of urban and rural Aboriginals as well as the
impact of being “Status Indians” on reservations. For the
non-Aboriginal group, our findings are in accord with
other studies which found that younger patients [15,16]
were more likely to leave AMA, and those with opiates as
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their scheduled treatment [36].
The following limitations merit discussion. First, the
information on substance use and drug-related diseases
were based on self-report. However, previous studies
have shown that patients’ self-reports of drug use are
reasonably reliable and valid to provide descriptions of
drug use, drug-related problems and the natural history
of drug use [37]. Self-reported HIV and HCV status,
however, likely under-represent the true prevalence of
these infections [38]. Second, we did not have data on
medication used during treatment and it is possible that
this could influence treatment dropout [15]. Third, this
study did not include assessment of psychiatric diagno-
ses, which previous literature has shown to be associated
with both pretreatment and treatment dropouts [39,40].
Conclusions
High pretreatment and treatment dropout rates may re-
flect the fact that the current addiction treatment system
fails to retain the clients. Therefore, examining risk fac-
tors that are associated with pretreatment and treatment
dropouts for Aboriginal and non-Aboriginal clients with
substance use disorders have very important policy impli-
cations. It can help policy makers better understand why
the system fails to retain the client and design and initiate
culturally appropriate services to improve the current ad-
diction treatment system. Specifically, our results highlight
the importance of social factors, such as homelessness and
timing of welfare check issuance for the Aboriginal popu-
lation compared to substance-specific factors (drug of
choice, for example) for the non-Aboriginal population.
Although the study findings were drawn from a detox ser-
vice in Vancouver DTES almost 10 years ago and since
then social housing and addiction services in Vancouver
have expanded [27]; however, factors associated with pre-
treatment and treatment dropouts, such as overrepresen-
tation of the Aboriginals in Vancouver DTES, timing of
welfare check issuance, and waiting times for detox still
exist, and therefore our findings remain pertinent in pro-
viding information that can help clinicians and decision-
makers design and initiate culturally appropriate services
to minimize pretreatment and treatment dropout rates
and therefore to improve the current addiction treatment
system for both Aboriginal and non-Aboriginal clients,
thereby improving clients’ physical and mental health
outcomes and increasing cost-effectiveness of treatment
resources.
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